Clinical Trial Update: Efficacy and Safety of Envafolimab Plus Doxorubicin and Ifosfamide for Advanced Soft Tissue Sarcoma [Phase 2]

View source ↗

Summary

An ongoing Phase 2 trial is evaluating the combination of envafolimab with doxorubicin and ifosfamide for advanced soft tissue sarcoma, assessing efficacy and s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Doxorubicin (doxorubicin)
• Envafolimab (envafolimab)
• IFOSFAMIDE (IFOSFAMIDE)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Soft Tissue Sarcoma | Phase 2 | Status: RECRUITING